Quantum-Si incorporated

QSI

US74765K1051

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 31/05/2024 BST			5-day change	1st Jan Change
1.52 ^USD	-2.88%		-6.17%	-24.38%

05-30	Quantum-Si Incorporated Announces Board Changes	CI
05-15	Transcript : Quantum-Si incorporated - Shareholder/Analyst Call

Quantum-Si Appoints Life Sciences and Diagnostics Industry Leader Jack Kenny to Its Board of Directors

May 23, 2023 at 12:11 pm

Quantum-Si incorporated announced the appointment of Jack Kenny, CEO of Meridian Bioscience Inc., to its Board of Directors.

Latest news about Quantum-Si incorporated

Quantum-Si Incorporated Announces Board Changes	05-30	CI
Transcript : Quantum-Si incorporated - Shareholder/Analyst Call	05-15
Transcript : Quantum-Si incorporated, Q1 2024 Earnings Call, May 09, 2024	05-09
Earnings Flash (QSI) QUANTUM-SI INCORPORATED Reports Q1 Revenue $457,000, vs. Street Est of $0.4M	05-09	MT
Quantum-Si Incorporated Reaffirms Earnings Guidance for the Full Year 2024	05-09	CI
Quantum-Si incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
Quantum-Si Incorporated Announces Upgrades to Analysis Software that will Provide Customers with Higher Data Output and Precision and Shorter Processing Time	04-30	CI
Quantum-Si Incorporated Appoints Paula Dowdy to the Board of Directors	03-21	CI
Transcript : Quantum-Si incorporated, Q4 2023 Earnings Call, Feb 29, 2024	02-29
Quantum-Si incorporated Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
Quantum-Si Incorporated Provides Earnings Guidance for the Full Year 2024	02-29	CI
Earnings Flash (QSI) QUANTUM-SI INCORPORATED Reports Q4 Revenue $400,000, vs. Street Est of $0.3M	02-29	MT
Quantum-Si incorporated Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-29	CI
Quantum-Si incorporated Expands Proteome Coverage and Increases Sequencing Output with New Enhancements to Its Next-Generation Protein Sequencing? Platform	02-05	CI
Quantum-Si Introduces Next-Generation Protein Sequencertm in Japan with Addition of New Distributor	01-18	CI
Quantum-Si Incorporated Introduces First Next-Generation Protein Sequencer in Japan with Addition of New Distributor, TOMY Digital Biology Co., Ltd	01-18	CI
Quantum-Si incorporated(NasdaqGM:QSI) dropped from NASDAQ Biotechnology Index	12-15	CI
Quantum-Si Incorporated Expands Global Reach with Addition of New Distributor, 3Genes Distribution a.s	12-12	CI
HC Wainwright Initiates Quantum-Si With Buy Rating, Price Target is $3	12-08	MT
Quantum-Si Incorporated Enters into Agreement with Elta 90 to Distribute Quantum-Si?s Groundbreaking Platinum Instrument and Consumables in Southeast Europe	11-15	CI
Earnings Flash (QSI) QUANTUM-SI INCORPORATED Reports Q3 Revenue $223,000, vs. Street Est of $400,000	11-09	MT
Quantum-Si incorporated Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
Transcript : Quantum-Si incorporated, Q3 2023 Earnings Call, Nov 09, 2023	11-09
Canaccord Genuity Downgrades Quantum-Si to Hold From Buy, Trims Price Target to $2 From $3.50	25/09/23	MT
Quantum-Si Incorporated Announces Appointment of Amir Jafri to Its Board of Directors	21/09/23	CI

Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.

Sector

Biotechnology & Medical Research

Calendar

06:30pm - American Society for Mass Spectrometry Meeting

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Quantum-Si incorporated

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1.52 USD

Average target price

2.75 USD

Spread / Average Target

+80.92%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
QUANTUM-SI INCORPORATED	-24.38%	216M
MODERNA, INC.	+43.36%	54.63B
IQVIA HOLDINGS INC.	-5.31%	39.92B
LONZA GROUP AG	+36.92%	38.82B
ICON PUBLIC LIMITED COMPANY	+14.75%	26.86B
CELLTRION, INC.	-12.56%	26.22B
ALNYLAM PHARMACEUTICALS, INC.	-22.45%	18.78B
UNITED THERAPEUTICS CORPORATION	+25.12%	12.21B
BIO-TECHNE CORPORATION	+0.04%	12.16B
MEDPACE HOLDINGS, INC.	+26.04%	11.94B

Other Biotechnology & Medical Research

Quantum-Si incorporated

Equities

QSI

US74765K1051

Biotechnology & Medical Research

Quantum-Si Appoints Life Sciences and Diagnostics Industry Leader Jack Kenny to Its Board of Directors

Latest news about Quantum-Si incorporated

Chart Quantum-Si incorporated

Company Profile

Income Statement Evolution

Ratings for Quantum-Si incorporated

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research